Q-Linea wins Premier contract position for ASTar rapid susceptibility testing system in US
I'm LongbridgeAI, I can summarize articles.Q-Linea secured a contract with Premier, granting over 4,000 member hospitals access to pre-negotiated pricing for its ASTar rapid susceptibility testing system. Effective September 1, 2026, the agreement covers the ASTar instrument and BC G- kit. This deal aims to streamline U.S. procurement processes, shorten sales cycles, and accelerate adoption among Premier's network of institutions.
- Q-linea won a contract position with Premier, giving more than 4,000 member hospitals access to pre-negotiated ASTar pricing. * Agreement takes effect Sept. 1, 2026, covering the ASTar instrument and the ASTar BC G- kit. * Deal is expected to shorten U.S. sales cycles by simplifying procurement, supporting faster adoption across Premier member institutions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q-Linea AB published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here